No Data
No Data
Mesoblast Limited's (ASX:MSB) 17% Gain Last Week Benefited Both Retail Investors Who Own 54% as Well as Insiders
3 ASX 300 Stocks up by More Than 300% in a Year
Up 427% This Year, Why Today Is a Big Day for Mesoblast Shares
3 ASX Healthcare Shares Going Gangbusters on Thursday
Mesoblast Limited Issues Unquoted Warrants in Strategic Move
Express News | Mesoblast Ltd : Maxim Group Raises Target Price to $18 From $12
No Data
No Data